Reductions in AFP and PIVKA-II can predict the efficiency of anti-PD-1 immunotherapy in HCC patients

BACKGROUND: Few biomarkers can predict the efficiency of PD-1 blockade in patients with hepatocellular carcinoma (HCC). This study aimed to investigate the prognostic role of AFP and PIVKA-II in HCC patients receiving anti-PD-1 immunotherapy. METHODS: A total of 235 HCC patients treated with PD-1 bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Sun, Xuqi, Mei, Jie, Lin, Wenping, Yang, Ziliang, Peng, Wei, Chen, Jinbin, Zhang, Yaojun, Xu, Li, Chen, Minshan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254996/
https://www.ncbi.nlm.nih.gov/pubmed/34218801
http://dx.doi.org/10.1186/s12885-021-08428-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8254996/
https://www.ncbi.nlm.nih.gov/pubmed/34218801
http://dx.doi.org/10.1186/s12885-021-08428-w

Ejemplares similares